Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Journal Title: 
Haematologica
Primary Author: 
Kosmider O
Author(s): 
Kosmider O, Passet M, Santini V, Platzbecker U, Andrieu V, Zini G, Beyne-Rauzy O, Guerci A, Masala E, Balleari E, Bulycheva E, Dreyfus F, Fenaux P, Fontenay M, Park S
Original Publication Date: 
Thursday, April 7, 2016

No abstract available.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.